HLA-A and HLA-DRB1 amino acid polymorphisms are associated with susceptibility and protection to pulmonary tuberculosis in a Greek population

Human Immunology

Volumn 73, Issue 6, 2012, Pages 641-646

  Magira, Eleni E ^a,b,c,d   Papasteriades, Chryssa ^c   Kanterakis, Stathis ^a,b   Toubis, Michalis ^e   Roussos, Charis ^d   Monos, Dimitri S ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c EVANGELISMOS HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; BCG VACCINE; DNA; GLUTAMINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; SERINE; TUBERCULIN;

ADULT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE PREDISPOSITION; DNA FINGERPRINTING; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GREECE; HISTOPATHOLOGY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULIN TEST;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GREECE; HLA-A ANTIGENS; HLA-DRB1 CHAINS; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; TUBERCULOSIS, PULMONARY;

EID: 84861769329     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.03.008     Document Type: Article

References (50)

1. Kaufmann S.H. Immunity to intracellular bacteria. Adv Immunol 1993, 11:129-163.
2. Schaible U.E., Collins H.L., Kaufmann S. Confrontation between intracellular bacteria and the immune system. Adv Immunol 1999, 71:267-377.
3. Kaufmann S.H. Cell-mediated immunity: dealing a direct blow to pathogens. Curr Biol 1999, 9:R97-R99.
4. Van der Wel N., Hava D., Houben D., Fluitsma D., Van Zon M., Pierson J., et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 2007, 129:1287-1298.
5. Ramachandra L., Chu R.S., Askew D., Noss E.H., Canaday D.H., Potter N.S., et al. Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses. Immunol Rev 1999, 168:217-239.
6. Flynn J.L., Goldstein M.M., Triebold K.J., Koller B., Bloom B.R. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992, 89:12013-12017.
7. Lazarevic V., Flynn J. CD8+ cells in tuberculosis. Am J Resp Crit Care Med 2002, 166:1116-1121.
8. WHO 2011 global tuberculosis control report. http://www.who.int/tb/publications/global_report/en/index.html.
9. Dye C., Shaele S., Dolin P., Pathani V., Raviglione M.C. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. J Am Med Assoc 1999, 282:677-686.
10. De Viedma D.G., Marin M., Susana Hernangomez S., Di{dotless}az M., Ruiz Serrano M.J., Alcala L., et al. Tuberculosis recurrences reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med 2002, 162:1873-1879.
11. Sokal J.E. Measurement of delayed skin-test responses. New Engl J Med 1975, 293:501-502.
12. Spyridis N.P., Spyridis P.G., Gelesme A., Sypsa V., Valianatou M., Metsou F., et al. Alone versus 3- and 4-month regimens of isoniazid plus rifampin for the effectiveness of a 9-month regimen of isoniazid treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis 2007, 45:715-722.
13. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1991;142:725-35.
14. American Thoracic Society. The tuberculin skin test. Am Rev Respir Dis 1981;124:356-63.
15. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009, Geneva; 2009. http://www.who.int/tb/publications/global_report.
16. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215-1218.
17. Buyse R., Decorte M., Baens Z. Rapid DNA typing of class II antigens using the PCR and reverse dot blot hybridization. Tissue Antigens 1993, 41:1-14.
18. Bunce M., O'Neill M., Barnardo M.C., Krausa P., Browning M.J., Morris P.J., et al. Phototyping-comprehensive DNA typing for HLA-A, HLA-B, HLA-C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46:355-367.
19. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet 1955, 19:251-253.
20. Svjegaard A., Ryder L.P. HLA and disease association: detecting the strongest association. Tissue Antigens 1994, 43:18-27.
21. Kanterakis S., Magira E., Rosenman K.D., Rossman M., Talsania K., Monos D.S. SKDM human leukocyte antigen (HLA) tool: a comprehensive HLA and disease associations analysis software. Hum Immunol 2008, 69:522-525.
22. Zerva L., Cizman B., Mehra N.K. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J Exp Med 1996, 183:829-836.
23. Rossman M., Stubbs J., Wha Lee C., Argyris E., Magira E., Monos D.S. Human leukocyte antigen class II amino acid epitopes susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 2002, 165:788-794.
24. Magira E.E., Papaioakim M., Nachamkin I., Asbury A.K., Li C.Y., Ho T.W., et al. Differential distribution of HLA-DQ-/DR- epitopes in the two forms of Guillain-Barré syndrome (GBS), acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ epitopes associated with susceptibility and protection to AIDP. J Immunol 2003, 170:3074-3079.
25. Monos D.S., Pappas J., Magira E.E., Gaughan J., Aplenc R., Sakkas L., et al. Identification of HLA-DQα and -DRβ residues associated with susceptibility and protection to epithelial ovarian cancer. Hum Immunol 2005, 66:554-562.
26. Matsuki K., Grumet F.C., Lin X., Gelb M., Guilleminault C., Dement W.C., et al. DQ (rather than DR) gene marks susceptibility to narcolepsy. The Lancet 1992, 339:1052.
27. *0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci USA 2004, 101:1999-2004.
28. Taheri S., Zeitzer J.M., Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Ann Rev Neurosci 2002, 25:283-313.
29. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. The Lancet 2000, 355:39-40.
30. *0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 1994, 180:873-883.
31. Chen Y.Z., Matsushita S., Nishimura Y. A single residue polymorphism at DR beta 37 affects recognition of peptides by T cells. Hum Immunol 1997, 54:30-39.
32. *1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population. Brit J Dermatol 1998, 139:978-983.
33. Wu Y., Chen Y., Li L., Cao Y., Liu Z., Liu B., et al. Polymorphic amino acids at codons 9 and 37 of HLA-DQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer 2006, 118:3006-3011.
34. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
35. Saper M.A., Bjorkman P.J., Wiley D.C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991, 219:277-319.
36. Peh C.A., Burrows S.R., Barnden M., Khanna R., Cresswell P., Moss D.J., et al. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 1998, 8:531.
37. Grandea A.G., Lehner P.J., Cresswell P., Spies T. Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetic 1997, 46:477-483.
38. Lehner P.J., Surman M.J., Cresswell P. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. Immunity 1998, 8:221-231.
39. Park B., Lee S., Kim E., Ahn K. A single polymorphic residue within the peptide-binding cleft of MHC class I molecules determines spectrum of tapasin dependence. J Immunol 2003, 170:961-968.
40. Chang S.T., Linderman J.J., Kirschner D.E. Effect of multiple genetic polymorphisms on antigen presentation and susceptibility to Mycobacterium tuberculosis infection. Infect Immun 2008, 76:3221-3232.
41. Nejentsev S., Howson J.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., et al. Wellcome Trust Case Control Consortium. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, 450:887-892.
42. Howson J.M., Walker N.M., Clayton D., Todd J.A. Type 1 Diabetes Genetics Consortium. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab 2009, (Suppl. 1):31-45.
43. *15:01. PLoS One 2010, 5(6):e11296.
44. Selvaraj P. Host genetics and tuberculosis susceptibility. Curr Sci 2004, 86:115-121.
45. Gutacker M.M., Mathema B., Soini H., Shashkina E., Kreiswirth B.N., Graviss E.A., et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Inf Dis 2006, 93:121-128.
46. Delgado J.C., Baena A., Thim S., Goldfeld A.E. Aspartic acid homozygosity at codon 57 of HLA-DQβ is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol 2006, 176:1090-1097.
47. Goldfield A.E., Delgano J.C., Thim S., Bozon M.V., Uglialoro A.M., Turbay D., et al. Association of an HLA-DQ allele with clinical tuberculosis. J Am Med Assoc 1998, 279:226-228.
48. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987, 329:599-604.
49. Jones E.Y., Fugger L., Strominger J.L., Siebold C. MHC class II proteins and disease: a structural perspective. Nature Rev Immunol 2006, 6:271-282.
50. Gazouli M., Ikonomopoulos J., Koundourakis A., Bartos M., Pavlik I., Overduin P., et al. Characterization of Mycobacterium tuberculosis complex isolates from Greek patients with sarcoidosis by spoligotyping. J Clin Microbiol 2005, 43:4858-4861.